Skip to main content
. 2020 Nov 5;12(11):1057. doi: 10.3390/pharmaceutics12111057

Figure 9.

Figure 9

Chromatographic impurity of TAFHF-CO (a) and TAFFB-SO (b) formulations within the implant at 180 days under various storage conditions.